KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 145 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $72,357,000 | -19.3% | 965,015 | -18.9% | 0.02% | -9.5% |
| Q2 2015 | $89,623,000 | +63.0% | 1,190,053 | +8.5% | 0.02% | +61.5% |
| Q1 2015 | $54,987,000 | +60.1% | 1,096,458 | +10.7% | 0.01% | +62.5% |
| Q4 2014 | $34,344,000 | +19.0% | 990,320 | +12.4% | 0.01% | 0.0% |
| Q3 2014 | $28,858,000 | -11.9% | 880,896 | +3.1% | 0.01% | -11.1% |
| Q2 2014 | $32,770,000 | +16.9% | 854,064 | +21.1% | 0.01% | +12.5% |
| Q1 2014 | $28,036,000 | +32.8% | 705,140 | +24.8% | 0.01% | +33.3% |
| Q4 2013 | $21,109,000 | +61.2% | 565,171 | +96.8% | 0.01% | +50.0% |
| Q3 2013 | $13,092,000 | +90.7% | 287,184 | +13.1% | 0.00% | +33.3% |
| Q2 2013 | $6,867,000 | – | 253,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |